Avadel Pharmaceuticals Gross Margin 2012-2025 | AVDL

Current and historical gross margin for Avadel Pharmaceuticals (AVDL) over the last 10 years. The current gross profit margin for Avadel Pharmaceuticals as of September 30, 2025 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Avadel Pharmaceuticals Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-09-30 $0.25B $0.24B 95.56%
2025-06-30 $0.22B $0.20B 90.05%
2025-03-31 $0.20B $0.18B 90.26%
2024-12-31 $0.17B $0.16B 91.72%
2024-09-30 $0.14B $0.13B 92.75%
2024-06-30 $0.10B $0.09B 95.79%
2024-03-31 $0.05B $0.05B 98.15%
2020-06-30 $0.05B $0.04B 78.72%
2020-03-31 $0.06B $0.04B 80.00%
2019-12-31 $0.06B $0.05B 79.66%
2019-09-30 $0.07B $0.06B 79.71%
2019-06-30 $0.08B $0.06B 81.33%
2019-03-31 $0.09B $0.07B 84.88%
2018-12-31 $0.10B $0.09B 84.47%
2018-09-30 $0.12B $0.10B 86.32%
2018-06-30 $0.14B $0.12B 87.59%
2018-03-31 $0.15B $0.14B 88.31%
2017-12-31 $0.17B $0.16B 90.80%
2017-09-30 $0.18B $0.17B 91.76%
2017-06-30 $0.17B $0.16B 91.95%
2017-03-31 $0.17B $0.15B 91.62%
2016-12-31 $0.15B $0.14B 90.67%
2016-09-30 $0.15B $0.14B 90.67%
2016-06-30 $0.17B $0.15B 92.12%
2016-03-31 $0.18B $0.16B 93.14%
2015-12-31 $0.17B $0.16B 93.02%
2015-09-30 $0.13B $0.13B 94.70%
2015-06-30 $0.09B $0.09B 92.39%
2015-03-31 $0.05B $0.05B 88.24%
2014-12-31 $0.03B $0.02B 85.19%
2014-09-30 $0.03B $0.03B 93.33%
2014-06-30 $0.03B $0.03B 93.10%
2014-03-31 $0.03B $0.03B 92.59%
2013-12-31 $0.02B $0.02B 95.65%
2013-09-30 $0.02B $0.02B 75.00%
2013-06-30 $0.02B $0.02B 78.26%
2013-03-31 $0.02B $0.02B 82.61%
2012-12-31 $0.03B $0.02B 84.00%
2012-09-30 $0.03B $0.02B 81.48%
2012-06-30 $0.03B $0.03B 84.38%
2012-03-31 $0.03B $0.03B 81.82%
2011-12-31 $0.03B $0.03B 78.79%
2011-09-30 $0.04B $0.03B 83.78%
2011-06-30 $0.04B $0.03B 82.86%
2011-03-31 $0.04B $0.03B 83.33%
2010-12-31 $0.04B $0.03B 83.78%
2010-09-30 $0.04B $0.03B 74.29%
2010-06-30 $0.04B $0.03B 70.27%
2010-03-31 $0.04B $0.03B 71.79%
2009-12-31 $0.04B $0.03B 74.42%
2009-09-30 $0.04B $0.03B 78.05%
2009-06-30 $0.04B $0.03B 80.00%
2009-03-31 $0.04B $0.03B 79.49%
2008-12-31 $0.04B $0.03B 76.32%
2008-09-30 $0.04B $0.03B 70.00%
2008-06-30 $0.04B $0.03B 65.00%
2008-03-31 $0.04B $0.02B 60.53%
2007-12-31 $0.04B $0.02B 54.05%
2007-09-30 $0.03B $0.02B 61.76%
2007-06-30 $0.03B $0.02B 66.67%
2007-03-31 $0.03B $0.02B 71.43%
2006-12-31 $0.02B $0.02B 78.26%
2006-09-30 $0.02B $0.02B 80.95%
2006-06-30 $0.02B $0.02B 78.95%
2006-03-31 $0.02B $0.02B 80.00%
2005-12-31 $0.02B $0.02B 91.30%
2005-09-30 $0.04B $0.03B 91.67%
2005-06-30 $0.05B $0.04B 93.48%
2005-03-31 $0.05B $0.05B 93.88%
2004-12-31 $0.06B $0.05B 94.55%
2004-09-30 $0.05B $0.04B 93.62%
2004-06-30 $0.04B $0.04B 92.31%
2004-03-31 $0.04B $0.03B 91.43%
2003-12-31 $0.03B $0.02B 80.00%
2003-09-30 $0.02B $0.01B 73.68%
2003-06-30 $0.02B $0.02B 80.00%
2003-03-31 $0.02B $0.02B 84.21%
2002-12-31 $0.02B $0.02B 95.00%
2002-09-30 $0.02B $0.02B 100.00%
2002-06-30 $0.02B $0.02B 100.00%
2002-03-31 $0.02B $0.02B 100.00%
2001-12-31 $0.01B $0.01B 100.00%
2001-09-30 $0.01B $0.01B 100.00%
2001-06-30 $0.01B $0.01B 100.00%
2001-03-31 $0.01B $0.01B 100.00%
2000-12-31 $0.01B $0.01B 100.00%
2000-09-30 $0.02B $0.02B 100.00%
2000-06-30 $0.01B $0.01B 100.00%
2000-03-31 $0.01B $0.01B 100.00%
1999-12-31 $0.01B $0.01B 100.00%
1999-06-30 $0.01B $0.01B 100.00%
1999-03-31 $0.01B $0.01B 100.00%
1998-12-31 $0.01B $0.01B 100.00%
1998-09-30 $0.01B $0.01B 100.00%
1998-06-30 $0.01B $0.01B 100.00%
1998-03-31 $0.01B $0.01B 100.00%
1997-12-31 $0.01B $0.01B 100.00%
1997-09-30 $0.01B $0.01B 100.00%
1997-06-30 $0.01B $0.01B 100.00%
1997-03-31 $0.01B $0.01B 100.00%
1996-12-31 $0.01B $0.01B 100.00%
1996-09-30 $0.01B $0.01B 100.00%
1996-06-30 $0.00B $0.00B 100.00%
1996-03-31 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.113B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00